Company Filing History:
Years Active: 2018
Title: The Innovations of William Bowen
Introduction
William Bowen is an accomplished inventor based in Madison, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations aimed at treating cancer. His work exemplifies the intersection of science and innovation, showcasing the potential of targeted therapies.
Latest Patents
William Bowen holds a patent for "Formulations of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione." This patent includes pharmaceutical compositions and single unit dosage forms of Compound A, which is crucial for developing effective cancer treatments. The patent outlines methods of treating, managing, or preventing cancer using the described dosage forms.
Career Highlights
Bowen is associated with Celgene Corporation, a leading biopharmaceutical company known for its innovative therapies. His role at Celgene has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His expertise in formulations has positioned him as a key player in the fight against cancer.
Collaborations
William Bowen has worked alongside notable colleagues, including Colin Walters and Yali Sun. Their collaborative efforts have further advanced the research and development of effective pharmaceutical solutions.
Conclusion
William Bowen's contributions to pharmaceutical innovations highlight the importance of targeted therapies in cancer treatment. His patent and work at Celgene Corporation reflect a commitment to improving patient outcomes through scientific advancements.